Cargando…
Targeting the glycans: A paradigm for host‐targeted and COVID‐19 drug design
There is always a need for new approaches for the control of virus burdens caused by seasonal outbreaks, the emergence of novel viruses with pandemic potential and the development of resistance to current antiviral drugs. The outbreak of the 2019 novel coronavirus‐disease COVID‐19 represented a pand...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242448/ https://www.ncbi.nlm.nih.gov/pubmed/34028178 http://dx.doi.org/10.1111/jcmm.16585 |